132 related articles for article (PubMed ID: 12029339)
1. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
3. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
[TBL] [Abstract][Full Text] [Related]
4. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
[TBL] [Abstract][Full Text] [Related]
5. Case report 701: Prostaglandin E1 (PGE1) periostitis.
Rowley RF; Lawson JP
Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
[TBL] [Abstract][Full Text] [Related]
6. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
[TBL] [Abstract][Full Text] [Related]
7. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
10. Relation of gastric distention to prostaglandin therapy in neonates.
Kriss VM; Desai NS
Radiology; 1997 Apr; 203(1):219-21. PubMed ID: 9122396
[TBL] [Abstract][Full Text] [Related]
11. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
12. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
Simões LC; Sarachaga IH; Quero M; Casanova M; Cazzaniga M; Villibre D
Arq Bras Cardiol; 1985 Jul; 45(1):31-6. PubMed ID: 3938651
[No Abstract] [Full Text] [Related]
13. Acute gastric outlet obstruction following the administration of prostaglandin: an additional case.
Kobayashi N; Aida N; Nishimura G; Kashimura T; Ohta M; Kawataki M
Pediatr Radiol; 1997 Jan; 27(1):57-9. PubMed ID: 8995170
[TBL] [Abstract][Full Text] [Related]
14. [Use of prostaglandins in neonatal cardiology].
Dinarević S; Kurtagić S; Maksić H
Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.
Buck ML
DICP; 1991 Apr; 25(4):408-9. PubMed ID: 1926911
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
Høst A; Halken S; Kamper J; Lillquist K
Dan Med Bull; 1988 Feb; 35(1):81-4. PubMed ID: 3342648
[TBL] [Abstract][Full Text] [Related]
18. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
[TBL] [Abstract][Full Text] [Related]
19. Aminophylline for the prevention of apnea during prostaglandin E1 infusion.
Lim DS; Kulik TJ; Kim DW; Charpie JR; Crowley DC; Maher KO
Pediatrics; 2003 Jul; 112(1 Pt 1):e27-9. PubMed ID: 12837902
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
